Poon, Jiat Ling
OHara, Louise
Kendal, Helen
Sully, Kate
Guy, Margaret
Bradley, Helena
Tolley, Chloe
Mason, Brad
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 2 January 2024
Accepted: 14 March 2024
First Online: 1 April 2024
Declarations
:
: Jiat Ling Poon is an employee and stockholder of Eli Lilly and Company. Louise OHara, Helen Kendal, Helena Bradley, and Brad Mason are employees of Adelphi Values Ltd. Kate Sully, Margaret Guy, and Chloe Tolley were employees of Adelphi Values Ltd at the time the research was conducted.
: The study was approved by the Western Copernicus Group Institutional Review Board (June 13, 2021; Study number: 1310521). All study data were accessed in compliance with the US patient confidentiality requirements, including the Health Insurance Portability and Accountability Act of 1996 regulations. The study was conducted in accordance with the Declaration of Helsinki. Eligible participants provided informed consent prior to study start, including consent for the publication of study data, and provided demographic data before the interviews.